Chicago Onglyza Lawsuit

A new FDA advisory meeting cautioned that the tags used on Onglyza must have clear warnings about the potential for heart failure, a warning that wasn’t included in the labels formerly. This absence of warnings has resulted in a rise in people injured by this medication filing Chicago Onglyza lawsuits.

Have you or your loved one taken Onglyza and suffered from heart failure? Well, you might qualify for compensation from the manufacturer, AstraZeneca. Of course, you ought to know that it is a huge company with a group of experienced mass tort attorneys in-house for handling such suits.

But you don’t need to worry because we’re here to assist. Contact us now. Our Chicago mass tort attorneys will give you a free consultation, review your claim, and also advise you on your legal rights.

Table of Contents

What’s the Link Between Onglyza Along With Heart Failure?

In America, cardiovascular diseases are some of the top causes of death for both men and women. Each year, the CDC (center for disease control) reports at least 610,000 fatalities because of cardiovascular disease. That means that at least 4 in every 4 deaths in the united states is because of cardiovascular disease in the US.

Individuals diagnosed with type 2 diabetes and prescribed by Onglyza have reported that an alarming rate of health issues linked to the usage of this medication. The FDA started investigating Onglyza and how it increases the chance of heart ailments especially after several concerns in the US. The concluding report demonstrated lots of stressful issues as such manufacturers of Onglyza and Kombiglyze XR need to add warnings of heart failure on the drug labels.

Is There A Link Between Onglyza And Pancreatic Cancer?

Therefore, it has been linked to people having problems with pancreatic cancer or pancreatitis. In 2013, a study focused on the way DPP-4 inhibitors affected the pancreas. The analysis revealed that individuals with type 2 diabetes who have been using Onglyza have an increased chance of receiving an enlarged pancreas.

Back in March 2013, the FDA issued a medication security alert revealing that the body was researching the suggestions that individuals using incretin mimetic to deal with type 2 diabetes have a higher risk of precancerous cellular changes and pancreatitis.

In 2014, another analysis was conducted by investigators who examined data gathered from a clinical trial for people with Onglyza. The study identified no symptoms of increased risk of pancreatitis or pancreatic cancer.

Victoza, similar to Onglyza, is an incretin mimetic recognized to induce severe pancreatitis and cancerous thyroid gland in rodents who were given the medication in clinical dosages. The FDA issued a safety warning in June 2011, notifying people of the danger of thyroid cancer by using Victoza.

Contact our firm to file your Chicago Onglyza lawsuit.

Has Onglyza Been Recalled?

There has been no recall of Onglyza yet and it’s a low probability that it will be done shortly. Besides these, the problems of cancer, heart failure, or other deadly health problems can’t be dismissed after using the drug. Vioxx was recalled since it caused heart attacks, strokes, and other cardiovascular issues. The same is expected of Onglyza and some other incretin mimetics known to increase heart failure. Currently, the only action that has been taken for all these drugs will be to authorize manufacturers to mention these side effects on the labels.

Are There Any Current Lawsuits Against Onglyza?

Drug injury suits are not ordinarily categorized as a class action. Note that, using a class action, a few plaintiffs will signify the others with similar cases against the medication manufacturers/company. You are required to submit the case individually. Back in January 2018, a judicial panel arranged that all the existing lawsuits against Onglyza and Kombiglyze ought to be consolidated in Kentucky. By May of the exact same year, 100 of these cases were merged into the lawsuit labeled MDL 2809. However, other lawsuits remain pending in California.

Can You File A Chicago Onglyza Lawsuit If It Has Not Been Recalled?

As previously mentioned, the FDA has recommended that each of the labels of Onglyza should have clear warnings about the risk of heart failure. But a lot of men and women are still asking why the warnings were not included when the product was released 10 decades ago. If this is what is happening now, then a lot of patients who shot Onglyza in the previous ten years were not aware of the higher heart risks. Therefore, they might have endured some significant side effects without an idea of the cause.

According to the legislation in Chicago patients that were prescribed Onglyza and suffered heart failure, are eligible for payment. That is because the drug manufacturers failed to provide people with sufficient safety warnings about the potential outcome.

Get Legal Assistance From An Onglyza Attorney

Have you or your loved one suffered heart difficulties or heart failure due to Onglyza? Has your loved one been hospitalized or died due to Onglyza? Well, you need to consult with the class action attorneys in our company. We are here in order to assist and have worked together with various people all over the country.

We’ve got the very best understanding of how large pharmaceutical companies such as AstraZeneca and Bristol Myers Squibb are mandated by law to make sure that patients and physicians know about the dangers associated with their medications. By failing to do this, these pharmaceutical companies are liable for any damages by people who have used their drugs.

Through time, we have handled similar drug cases to Onglyza. As such, we understand all of the defects associated with such a circumstance. If you would like to face the medication manufacturers behind Onglyza, we ought to be your first choice of lawyers. We can ensure you win the situation and get the right compensation for your damages. We will do a comprehensive overview of your situation and provide you more information about your rights as a plaintiff.

Related Articles